Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.33 USD | +0.96% |
|
-10.21% | -24.10% |
Business Summary
Number of employees: 13
Managers
Managers | Title | Age | Since |
---|---|---|---|
Enrique Poradosu
FOU | Founder | 58 | 26/07/20 |
Shay Shemesh
FOU | Founder | 41 | 26/07/20 |
Ronald Bentsur
CEO | Chief Executive Officer | 58 | 26/07/20 |
Michael Carson
DFI | Director of Finance/CFO | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Ronald Bentsur
CEO | Chief Executive Officer | 58 | 26/07/20 |
Matt Kaplan
BRD | Director/Board Member | 56 | 31/08/21 |
Kenneth Hoberman
BRD | Director/Board Member | 59 | 30/06/21 |
James Oliviero
BRD | Director/Board Member | 48 | 30/06/21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 18,356,060 | 8,420,873 ( 45.88 %) | 0 | 45.88 % |
Company contact information
![address Nuvectis Pharma, Inc.(NVCT)](https://cdn.zonebourse.com/static/address/130089463.png)
Sector
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.10% | 116M | |
+15.20% | 121B | |
+19.67% | 113B | |
+18.95% | 26.02B | |
-23.86% | 19.39B | |
-19.03% | 15.91B | |
-20.90% | 15.09B | |
-46.14% | 15.06B | |
+63.85% | 14.93B | |
+4.49% | 13.85B |
- Stock Market
- Equities
- NVCT Stock
- Company Nuvectis Pharma, Inc.